Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Weissler

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Oral Oncology|August 22, 2020
Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck - Mature clinical and functional outcomesTrevor G Hackman, Samip N Patel, Allison M Deal, et al.
Oral Oncology|June 18, 2016
Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of lifeKyle Wang, Robert J Amdur, William M Mendenhall, et al.
The Laryngoscope|November 10, 2020
Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer OutcomesNicholas R Lenze, Douglas Farquhar, Siddharth Sheth, et al.
Oral Oncology|June 23, 2021
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinomaNicholas R Lenze, Douglas R Farquhar, Siddharth Sheth, et al.
Journal of Geriatric Oncology|September 24, 2013
Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysisNoam A VanderWalde, Anne-Marie Meyer, Huan Liu, et al.
Head & Neck|July 4, 2020
Access to preventive care services and stage at diagnosis in head and neck cancerDouglas R Farquhar, Nicholas R Lenze, Maheer M Masood, et al.
Oral Oncology|June 4, 2020
Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancerDouglas R Farquhar, Andrew J Coniglio, Maheer M Masood, et al.
Oral Oncology|August 12, 2017
Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancersDominic H Moon, Sung Ho Moon, Kyle Wang, et al.
Cancer|May 10, 2018
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neckJared M Weiss, Juneko E Grilley-Olson, Allison Mary Deal, et al.
Translational Cancer Research|October 21, 2024
Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital typeDouglas R Farquhar, Nicholas R Lenze, Jason Tasoulas, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Oral Oncology|August 22, 2020
Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck - Mature clinical and functional outcomesTrevor G Hackman, Samip N Patel, Allison M Deal, et al.
Oral Oncology|June 18, 2016
Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of lifeKyle Wang, Robert J Amdur, William M Mendenhall, et al.
The Laryngoscope|November 10, 2020
Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer OutcomesNicholas R Lenze, Douglas Farquhar, Siddharth Sheth, et al.
Oral Oncology|June 23, 2021
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinomaNicholas R Lenze, Douglas R Farquhar, Siddharth Sheth, et al.
Journal of Geriatric Oncology|September 24, 2013
Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysisNoam A VanderWalde, Anne-Marie Meyer, Huan Liu, et al.
Head & Neck|July 4, 2020
Access to preventive care services and stage at diagnosis in head and neck cancerDouglas R Farquhar, Nicholas R Lenze, Maheer M Masood, et al.
Oral Oncology|June 4, 2020
Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancerDouglas R Farquhar, Andrew J Coniglio, Maheer M Masood, et al.
Oral Oncology|August 12, 2017
Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancersDominic H Moon, Sung Ho Moon, Kyle Wang, et al.
Cancer|May 10, 2018
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neckJared M Weiss, Juneko E Grilley-Olson, Allison Mary Deal, et al.
Translational Cancer Research|October 21, 2024
Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital typeDouglas R Farquhar, Nicholas R Lenze, Jason Tasoulas, et al.
Pageof 8